Financing channel feed

One mi­cro­cap biotech is charg­ing head­first in­to treach­er­ous IPO wa­ters, jump­ing to Nas­daq with mod­est raise

4 years ago

Biotech bil­lion­aire Di­et­mar Hopp digs deep­er to back one of the drug de­vel­op­ers in his port­fo­lio

4 years ago

With $200M in new cash, Syn­thego wants to be­come the man­u­fac­tur­ing bedrock for CRISPR. But where are its cus­tomers?

4 years ago
Startups
Manufacturing

Some genes are too large to fit in­to AAV vec­tors. UCB, No­var­tis back $57M idea to de­liv­er them in parts in­stead

4 years ago
Startups
Cell/Gene Tx

Au­dentes’ for­mer CEO launch­es new biotech, with $155M for hives and in­flam­ma­tion

4 years ago
Startups

A new start­up sets course against a con­stel­la­tion of rare dis­eases with a first shot re­pur­pos­ing the SIRP path­way

4 years ago
Startups

AI start­up grabs $60M, un­veils plat­form aimed at drug dis­cov­ery's 'da­ta prob­lem'

4 years ago
Startups
AI

In putting to­geth­er a $236M Se­ries D, one biotech spurns Nas­daq and sig­nals the dim­ming al­lure of IPOs

4 years ago

Roche-backed biotech re­fu­els with $40M to steer neu­ro­mus­cu­lar can­di­date to­ward late-stage tri­als

4 years ago

Look­ing for a quick di­ag­no­sis of your symp­toms? This biotech is build­ing an app for that

4 years ago
Diagnostics

Fu­ji­film stays hot, launch­es $60M in­vest­ment fund for new deals

4 years ago
Manufacturing

As it pre­pares to join EQT, Life Sci­ence Part­ners sur­pass­es €1B in­vest­ment mark

4 years ago

Cell ther­a­py pi­o­neer Mark Frohlich takes the helm at tiny In­dap­ta as a suite of big-name back­ers jump aboard

4 years ago
People
Startups

A small Seat­tle biotech wants to take on Glax­o­SmithK­line's emerg­ing Shin­grix block­buster. RA Cap­i­tal is on board

4 years ago
Startups

The 2022 top 100 bio­phar­ma in­vestors: A look back on boom times

4 years ago
Deals
Special

Up­dat­ed: RA Cap­i­tal and Soft­Bank head up the lat­est nine-fig­ure crossover, this time for Ven­tus. Will an IPO soon fol­low?

4 years ago

New Or­biMed-backed biotech aims to repli­cate Ver­tex's wild­ly suc­cess­ful cys­tic fi­bro­sis pills in oth­er dis­eases

4 years ago
Startups

Konek­sa lands new round of funds to de­vel­op app-based dig­i­tal bio­mark­er tech

4 years ago

‘We’re not that com­pa­ny’: John Hood is build­ing a biotech the old-fash­ioned way — and not just be­cause he has to now

4 years ago

Biotech bear mar­ket be damned, CAR-T play­er Ar­cel­lx rais­es $123M IPO

4 years ago
Cell/Gene Tx

Soft­Bank leads $150M round in­to Dew­point as con­den­sate biotech nears clin­ic

4 years ago

A faster 'pro­tein print­er' out of the UK earns new round of fund­ing with plans to ex­pand plat­form

4 years ago
Discovery

Cryo-EM fo­cused biotech from long­time NIH vet­er­an se­cures $40M back­ing from Bay­er in Se­ries A

4 years ago

UK biotechs smash 2020 in­vest­ment records, sur­pass­ing San Diego in VC and IPO rais­es

4 years ago
First page Previous page 58596061626364 Next page Last page
A service from the Financial Times